Japan Mulls Two Bills To Spur Local Regenerative-Medicine Industry
This article was originally published in PharmAsia News
Executive Summary
Japan legislators are considering two measures that could enable drug makers to get regenerative medicines to the market faster and easier than possible under the current regulatory regime.